| Bioactivity | RGD-targeted Proapoptotic Peptide is a peptide. The C-terminal RGD-4C peptide (ACDCRGDCFC) binds preferentially to integrins at sites of tumor angiogenesis. |
| Name | RGD-targeted Proapoptotic Peptide |
| CAS | 2243207-09-0 |
| Sequence | Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly-Gly-{d-Lys}-{d-Leu}-{d-Ala}-{d-Lys}-{d-Leu}-{d-Ala}-{d-Lys}-{d-Lys}-{d-Leu}-{d-Ala}-{d-Lys}-{d-Leu}-{d-Ala}-{d-Lys} (Disulfide bridge:Cys2-Cys10;Cys4-Cys8) |
| Shortening | ACDCRGDCFCGG-{d-K}-{d-L}-{d-A}-{d-K}-{d-L}-{d-A}-{d-K}-{d-K}-{d-L}-{d-A}-{d-K}-{d-L}-{d-A}-{d-K} (Disulfide bridge:Cys2-Cys10;Cys4-Cys8) |
| Formula | C116H199N35O31S4 |
| Molar Mass | 2708.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
RGD-targeted Proapoptotic Peptide
CAS: 2243207-09-0 F: C116H199N35O31S4 W: 2708.30
RGD-targeted Proapoptotic Peptide is a peptide. The C-terminal RGD-4C peptide (ACDCRGDCFC) binds preferentially to integ
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.